ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,094.40
      2.04%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.565
      1.34%
      Bitcoin
      66,421.15
      -0.67%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Blueprint Medicines Corporation (BPMC)

      7. Blueprint Medicines Corporation (BPMC) News

      BPMC Blueprint Medicines Corporation

      92.29
      1.68 (1.85%)
      After Hours
      Last Updated: 17:30:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Blueprint Medicines Corporation BPMC NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      1.68 1.85% 92.29 17:30:00
      Open Price Low Price High Price Close Price Prev Close
      90.48 89.19 94.67 92.29 90.61
      more quote information »

      Recent News

      Date Time Source Heading
      4/18/202408:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
      4/11/202408:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
      4/04/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
      3/11/202418:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
      3/06/202410:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202418:19EDGAR2Form 144 - Report of proposed sale of securities
      3/01/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/28/202416:03EDGAR2Form 144 - Report of proposed sale of securities
      2/23/202408:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
      2/22/202408:20EDGAR2Form 8-K - Current report
      2/16/202416:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/15/202417:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/15/202407:05EDGAR2Form 8-K - Current report
      2/15/202407:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
      2/14/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
      2/01/202408:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
      1/29/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/25/202416:13EDGAR2Form 144 - Report of proposed sale of securities
      1/08/202408:03EDGAR2Form 8-K - Current report
      1/08/202408:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
      1/05/202416:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
      12/26/202316:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202316:09EDGAR2Form 144 - Report of proposed sale of securities
      12/19/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202308:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
      12/15/202316:23EDGAR2Form 144 - Report of proposed sale of securities
      12/13/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202308:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
      12/11/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/09/202312:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
      12/07/202318:09EDGAR2Form 144 - Report of proposed sale of securities
      12/06/202320:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      BPMC
      Blueprint Medicines
      Delayed Upgrade Clock